Sphera Funds Management »

Precision Biosciences shares owned by Sphera Funds Management

Quarter-by-quarter ownership of Precision Biosciences (DTIL) shares owned by Sphera Funds Management from 13F filings

Historical chart of Sphera Funds Management investment in Precision Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Precision Biosciences held by Sphera Funds Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Precision Biosciences by Sphera Funds Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.6M 396k 4.16

More positions owned by Sphera Funds Management

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Biogen Idec (BIIB)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)
NOVA MEASURING Instruments L (NVMI)
Ultragenyx Pharmaceutical (RARE)
Tower Semiconductor Shs New (TSEM)
Cogent Biosciences (COGT)
Astrazeneca Sponsored Adr
Praxis Precision Medicines I Com New Call Option (PRAX)
Sanofi Sa Sponsored Adr (SNY)
Eli Lilly & Co. (LLY)
Amicus Therapeutics (FOLD)
Immatics SHS (IMTX)
BioMarin Pharmaceutical (BMRN)

View all positions for Sphera Funds Management

Top funds holding Precision Biosciences

Empery Asset Management
Standard Life Aberdeen
Octagon Capital Advisors
Bleichroeder
Boothbay Fund Management
Lynx1 Capital Management
Vanguard Group
Alyeska Investment Group
Sphera Funds Management
Renaissance Technologies
Geode Capital Management
BlackRock
683 Capital Management
Commonwealth Equity Services
Northern Trust

View all funds holding Precision Biosciences